Department of Endocrinology, Diabetes and Rheumatology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Horm Metab Res. 2012 Jun;44(7):527-32. doi: 10.1055/s-0032-1314786. Epub 2012 Jun 11.
For the diagnosis of primary aldosteronism (PA), confirmatory testing is mandatory and different function tests can be employed. There are, however, sparse data comparing the fludrocortisone suppression test (FST) and the saline infusion test (SIT). Patients with PA (n=90) or essential hypertension (n=65) were studied. They underwent one or the other test or both of them. Using the DPC Siemens aldosterone radioimmunoassay, we found that the SIT led to a stronger suppression of aldosterone than the FST. Post-test aldosterone-to-renin ratios (ARRs) and the percentage of suppression of aldosterone serum concentrations performed worse. The same results were observed in patients who underwent both FST and SIT. Some patients had divergent results in both tests. For the SIT, a lower cutoff value should be used than for the FST for the adequate identification of patients with unilateral PA. Long-term prospective studies are needed to address the question at what cutoff values patients benefit from subtype differentiation of PA. We discuss here possible explanations for divergent results obtained with both tests.
为了诊断原发性醛固酮增多症(PA),必须进行确证性检测,可以采用不同的功能检测。然而,比较氟氢可的松抑制试验(FST)和盐水输注试验(SIT)的研究数据很少。研究了 90 例 PA 患者和 65 例原发性高血压患者。他们接受了一项或另一项检查,或者同时接受了两项检查。使用 DPC 西门子醛固酮放射免疫测定法,我们发现 SIT 导致醛固酮的抑制作用强于 FST。试验后醛固酮-肾素比值(ARR)和醛固酮血清浓度抑制率较低。在同时接受 FST 和 SIT 的患者中也观察到了相同的结果。一些患者在两项检查中都有不同的结果。对于 SIT,应该使用比 FST 更低的截断值来充分识别单侧 PA 患者。需要进行长期前瞻性研究,以确定在什么截断值下,PA 的亚组分化会使患者受益。我们在这里讨论了两项检查结果不一致的可能解释。